George King Single Donor Normal Control Kit contains fresh frozen citrated human
George King Single Donor Normal Control Kit contains fresh frozen citrated human plasmas derived from non-medicated, non-smoking donors between the ages of 18 and 65 years of age. The kit is intended for use in establishing controlling reference ranges for coagulation assays.
GNN
Antisera, Neutralization, Coxsackievirus A 1-24, B 1-6
George King Single Donor Normal Control Kit contains fresh frozen citrated human
George King Single Donor Normal Control Kit contains fresh frozen citrated human plasmas derived from non-medicated, non-smoking donors between the ages of 18 and 65 years of age. The kit is intended for use in establishing controlling reference ranges for coagulation assays.
The George King Coumadin® Plasma Kit is a convenience control kit that contains
The George King Coumadin® Plasma Kit is a convenience control kit that contains citrated human fresh frozen plasma from donors on Coumadin® therapy. Each kit contains control material with six different INR levels.
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 20 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10
George King Abnormal Correlation (AbCOR) Kit is a convenience kit containing 10 vials of select control material that can be used to correlate reagent lot numbers and/or instrument platforms. (individual product inserts are included with each kit)
George King Pooled Normal Plasma is fresh frozen citrated human plasma is intend
George King Pooled Normal Plasma is fresh frozen citrated human plasma is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. it may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT and/or aPTT.
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX deficient donors
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX deficient donors
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma
George King von Willebrand plasma, Type 1, is citrated human fresh frozen plasma derived from a donor diagnosed with vWD Type 1. This plasma is intended for use as a control in the quantitative determination of von Willebrand Ag in citrated plasma.
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX Deficient donors
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX Deficient donors
George King Multi-Coumadin® Kit is citrated fresh frozen human plasma derived fr
George King Multi-Coumadin® Kit is citrated fresh frozen human plasma derived from donors stabilized on Coumadin® therapy and is intended for use as a control in the quantitative determination of the INR using the clottable prothrombin time assay.
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX Deficient donors
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged PT or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged PT and.or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) ad/or aPTT.
George King CFD is a Congenital Factor Deficient Convenience Kit which contains
George King CFD is a Congenital Factor Deficient Convenience Kit which contains five different factor deficient plasma's for product evaluation
GJT
Plasma, Coagulation Factor Deficient
2
George King Congential Factor Deficiency Convenience Kit
George King Single Donor Normal Plasma is fresh frozen citrated human plasma and
George King Single Donor Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.
George King FACT is a normal fresh frozen citrated control that is used to verif
George King FACT is a normal fresh frozen citrated control that is used to verify the performance of an assay intended to be used for the quantitative determination of multiple coagulation factors, intermediates and/or activated components.
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King A-FACT is a low abnormal fresh frozen citrated control that is used
George King A-FACT is a low abnormal fresh frozen citrated control that is used to verify the performance of an assay intended to be used for the quantitative determination of multiple coagulation factors, intermediates and/or activated components.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
The AMR Coagulation Kit is a convenience kit that contains three levels of contr
The AMR Coagulation Kit is a convenience kit that contains three levels of control material that can be used to verify the analytical measurement range of the eight different assays.
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma d
George King Positive Lupus Anticoagulant is citrated human fresh frozen plasma derived from donors who have been diagnosed with the Anti-Phospholipid Antibody Syndrome. (APS)
George King A-FACT is a low abnormal fresh frozen citrated control that is used
George King A-FACT is a low abnormal fresh frozen citrated control that is used to verify the performance of an assay intended to be used for the quantitative determination of multiple coagulation factors, intermediates and/or activated components.
George King FACT is a normal fresh frozen citrated control that is used to verif
George King FACT is a normal fresh frozen citrated control that is used to verify the performance of an assay intended to be used for the quantitative determination of multiple coagulation factors, intermediates and/or activated components.
George King FACT is a normal fresh frozen citrated control that is used to verif
George King FACT is a normal fresh frozen citrated control that is used to verify the performance of an assay intended to be used for the quantitative determination of multiple coagulation factors, intermediates and/or activated components.
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX Deficient donors.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is i
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen human citrated plasma and is in
George King Pooled Normal Plasma is fresh frozen human citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated human plasma is intend
George King Pooled Normal Plasma is fresh frozen citrated human plasma is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma der
George King Factor IX Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor IX Deficient donors
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is in
George King Pooled Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended
George King Pooled Normal Plasma is fresh frozen citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time assay (PT), the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay. It may also be used as the normal pooled plasma for mixing studies in the determination of a prolonged (PT) and/or aPTT.
George King Single Donor Normal Plasma is fresh frozen citrated human plasma and
George King Single Donor Normal Plasma is fresh frozen citrated human plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.
George King Factor VII Deficient Plasma is a fresh frozen citrated human plasma
George King Factor VII Deficient Plasma is a fresh frozen citrated human plasma derived from congenital Factor VII deficient donors.
George King Factor X Deficient Plasma is a fresh frozen citrated human plasma de
George King Factor X Deficient Plasma is a fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Factor X Deficient Plasma is fresh frozen citrated human plasma deri
George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Factor X Deficient Plasma is fresh frozen citrated human plasma deri
George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Factor X Deficient Plasma is fresh frozen citrated human plasma deri
George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Factor X Deficient Plasma is fresh frozen citrated human plasma deri
George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Factor X Deficient Plasma is fresh frozen citrated human plasma deri
George King Factor X Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor X deficient donors.
George King Prekallikrein Deficient plasma is fresh frozen citrated human plasma
George King Prekallikrein Deficient plasma is fresh frozen citrated human plasma derived from congenital Prekallikrein Deficient donors.
George King Single Donor Normal Plasma is fresh frozen human citrated plasma and
George King Single Donor Normal Plasma is fresh frozen human citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.
George King Factor VIII Deficient Plasma is fresh frozen citrated human plasma d
George King Factor VIII Deficient Plasma is fresh frozen citrated human plasma derived from congenital Factor VIII Deficient donors
George King Single Donor Normal Plasma is fresh frozen human citrated plasma and
George King Single Donor Normal Plasma is fresh frozen human citrated plasma and is intended to be used as a normal control for the one-stage prothrombin time (PT) assay, the activated partial thromboplastin time (aPTT) assay and the fibrinogen assay.
Control plasma for assays aimed to determine the functional phenotype for activa
Control plasma for assays aimed to determine the functional phenotype for activated protein C resistance caused by the Factor V Leiden mutation (FV:Q506).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.
ROTROL P is a quality control material for monitoring accuracy and precision of
ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
ROTROL N is a quality control material for monitoring accuracy and precision of
ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp.
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The in-tem® assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the intrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)).
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l
The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.